Catalyst
Slingshot members are tracking this event:
Corbus Pharma (CRBP) Releases Phase 2 Results Evaluating Resunab in Diffuse Cutaneous Systemic Sclerosis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CRBP |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 14, 2016
Related Projects
- Discussing the Potential for Success of Corbus' (CRBP) Lenabasum in Systemic Sclerosis before Phase 3 data "this summer" CRBP Executed On: Aug 21, 2020 at 01:00 PM EDT
Related Keywords
Phase 2, Results, Resunab, Diffuse Cutaneous Systemic Sclerosis
